Grants and Contributions:
Title:
Evaluation of molecules proposed to modulate miR processivity
Agreement Number:
969160
Agreement Value:
$30,000.00
Agreement Date:
Apr 1, 2021 - Mar 31, 2022
Description:
This project aims to provide in vitro biophysical data as proof-of-concept for a drug discovery platform that targets misexpressed miRNA. This pilot study investigates therapeutic targets of Parkinson's disease and pulmonary fibrosis, a sequela of COVID-19 infection.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Victoria, British Columbia, CA V8S 4T8
Reference Number:
172-2020-2021-Q4-969160
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
703340513
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 75 days.
Amendment Date
Jan 13, 2022
Recipient's Legal Name:
Azor Biotek Inc.
Federal Riding Name:
Victoria
Federal Riding Number:
59041
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: